UNSPSC 51343003: Tipranavir

This classification denotes a protease inhibitor with the molecular formula C31H33F3N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZZT404XD09, chemically known as 2-pyridinesulfonamide, n-(3-((1r)-1-((6r)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2h-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)- but generally known as tipranavir, which bears US NIH Compound Identifier 65027. European Medicines Agency schedules Tipranavir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04883MIG.

UNSPSC 51343003 Tipranavir, a Commodity code, does not align with the state and local contract opportunities recently tagged under it. The code nominally identifies a specific antiretroviral pharmaceutical, but the recent solicitations tracked under this code span naloxone and drug deactivation systems, direct-to-manufacturer pharmacy programs, fire department medical and first aid supplies, and multi-source generic pharmaceuticals and over-the-counter products—none of which are tipranavir or directly related to it. The mismatch suggests either a tagging error in the source data or a taxonomy assignment that does not reflect the work actually being procured under this code number in state and local markets.

The recent opportunities themselves show substantial pharmaceutical and medical supply procurement activity across multiple issuing bodies—including Seminole County, Florida (health department naloxone and drug deactivation systems), the Texas Health and Human Services Commission (pharmacy benefit direct-to-manufacturer capability exploration), the City of Tampa (fire department medical and first aid supplies), and the Minnesota Multistate Cooperative Purchasing Alliance serving multiple state and local members. Geographic spread encompasses Florida, Texas, Minnesota, and Oregon. However, because these solicitations do not substantively address tipranavir or the code's nominal scope, this code shows little relevant recent activity for business development purposes.